Maccarrone M et al. |
Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction. |
2005 |
J. Cell. Sci. |
pmid:16144868
|
Wang Y et al. |
VR1-mediated depressor effects during high-salt intake: role of anandamide. |
2005 |
Hypertension |
pmid:16144988
|
Sancho R et al. |
Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine. |
2005 |
J. Immunol. |
pmid:16148147
|
Hayase T et al. |
Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands. |
2005 |
Behav Pharmacol |
pmid:16148444
|
Yang W et al. |
Enzymatic formation of prostamide F2alpha from anandamide involves a newly identified intermediate metabolite, prostamide H2. |
2005 |
J. Lipid Res. |
pmid:16150817
|
Gasperi V et al. |
Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. |
2005 |
Neurotoxicology |
pmid:16154199
|
Sun YX et al. |
Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. |
2005 |
Biochim. Biophys. Acta |
pmid:16154384
|
Underdown NJ et al. |
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. |
2005 |
Br. J. Pharmacol. |
pmid:16158067
|
Barun S et al. |
Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips. |
2005 |
Clin. Exp. Pharmacol. Physiol. |
pmid:16173925
|
Bazinet RP et al. |
Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain. |
2005 |
Neurochem. Res. |
pmid:16176062
|
Straiker A and Mackie K |
Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. |
2005 |
J. Physiol. (Lond.) |
pmid:16179366
|
Battista N et al. |
Endocannabinoids and their involvement in the neurovascular system. |
2004 |
Curr Neurovasc Res |
pmid:16185189
|
Engeli S et al. |
Activation of the peripheral endocannabinoid system in human obesity. |
2005 |
Diabetes |
pmid:16186383
|
Schmidt A et al. |
Determination of the endocannabinoid anandamide in human plasma by high-performance liquid chromatography. |
2006 |
Biomed. Chromatogr. |
pmid:16189813
|
Li C et al. |
High affinity electrophilic and photoactivatable covalent endocannabinoid probes for the CB1 receptor. |
2005 |
J. Med. Chem. |
pmid:16190768
|
Singh Tahim A et al. |
Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons. |
2005 |
Neuroscience |
pmid:16198486
|
Tzavara ET et al. |
Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. |
2006 |
Biol. Psychiatry |
pmid:16199010
|
Mechoulam R |
Plant cannabinoids: a neglected pharmacological treasure trove. |
2005 |
Br. J. Pharmacol. |
pmid:16205721
|
Thomas A et al. |
Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. |
2005 |
Br. J. Pharmacol. |
pmid:16205722
|
Urbani P et al. |
New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies. |
2006 |
Bioorg. Med. Chem. Lett. |
pmid:16213718
|
Van Sickle MD et al. |
Identification and functional characterization of brainstem cannabinoid CB2 receptors. |
2005 |
Science |
pmid:16224028
|
Jiang W et al. |
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. |
2005 |
J. Clin. Invest. |
pmid:16224541
|
Malfitano AM et al. |
Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis. |
2006 |
J. Neuroimmunol. |
pmid:16239036
|
Di S et al. |
Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. |
2005 |
J. Physiol. (Lond.) |
pmid:16239276
|
Cabranes A et al. |
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. |
2005 |
Neurobiol. Dis. |
pmid:16242629
|
Kim HI et al. |
Anandamide suppression of Na+ currents in rat dorsal root ganglion neurons. |
2005 |
Brain Res. |
pmid:16256960
|
Sarnataro D et al. |
Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. |
2005 |
FEBS Lett. |
pmid:16263116
|
Kadoi Y et al. |
Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats. |
2005 |
Crit. Care Med. |
pmid:16276190
|
Glaser ST et al. |
Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain. |
2006 |
J. Pharmacol. Exp. Ther. |
pmid:16278311
|
Brizzi A et al. |
Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors. |
2005 |
J. Med. Chem. |
pmid:16279794
|
Ligresti A et al. |
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis. |
2006 |
Br. J. Pharmacol. |
pmid:16284631
|
Bir LS and Ercan S |
Effects of intrathecal anandamide on somatosensory evoked responses in rats. |
2006 |
Exp. Neurol. |
pmid:16289169
|
Mechoulam R and Deutsch DG |
Toward an anandamide transporter. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16314567
|
Suplita RL et al. |
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. |
2006 |
Neuropharmacology |
pmid:16316669
|
Juan-Picó P et al. |
Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. |
2006 |
Cell Calcium |
pmid:16321437
|
Cannizzaro C et al. |
Presynaptic effects of anandamide and WIN55,212-2 on glutamatergic nerve endings isolated from rat hippocampus. |
2006 |
Neurochem. Int. |
pmid:16325966
|
Rösch S et al. |
R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells. |
2006 |
J. Pharmacol. Exp. Ther. |
pmid:16330497
|
Hejazi N et al. |
Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. |
2006 |
Mol. Pharmacol. |
pmid:16332990
|
Flygare J et al. |
Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma. |
2005 |
FEBS Lett. |
pmid:16337199
|
Lizanecz E et al. |
Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1. |
2006 |
Mol. Pharmacol. |
pmid:16338989
|
Grimaldi C et al. |
Anandamide inhibits adhesion and migration of breast cancer cells. |
2006 |
Exp. Cell Res. |
pmid:16343481
|
Siegmund SV and Brenner DA |
Molecular pathogenesis of alcohol-induced hepatic fibrosis. |
2005 |
Alcohol. Clin. Exp. Res. |
pmid:16344593
|
Varvel SA et al. |
Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task. |
2006 |
J. Pharmacol. Exp. Ther. |
pmid:16352706
|
Gobbi G et al. |
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16352709
|
Bojesen IN and Hansen HS |
Effect of an unstirred layer on the membrane permeability of anandamide. |
2006 |
J. Lipid Res. |
pmid:16365480
|
Ligresti A et al. |
Endocannabinoid metabolic pathways and enzymes. |
2005 |
Curr Drug Targets CNS Neurol Disord |
pmid:16375679
|
Bai X et al. |
TASK channel expression in human placenta and cytotrophoblast cells. |
2006 |
J. Soc. Gynecol. Investig. |
pmid:16378911
|
Eljaschewitsch E et al. |
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. |
2006 |
Neuron |
pmid:16387640
|
D'Argenio G et al. |
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. |
2006 |
FASEB J. |
pmid:16403786
|
Nakajima Y et al. |
Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. |
2006 |
FEBS Lett. |
pmid:16406050
|